MDMA Therapy Is Rejected by FDA Panel

Scientific advisers vote overwhelmingly that the risks of MDMA treatment for post-traumatic stress disorder outweigh the benefits

 Scientific advisers vote overwhelmingly that the risks of MDMA treatment for post-traumatic stress disorder outweigh the benefits  Scientific American Content: Global

Leave a Reply

Your email address will not be published. Required fields are marked *